Foot infections in diabetic patients : decision and cost-effectiveness analysesECKMAN, M. H; GREENFIELD, S; MACKEY, W. C et al.JAMA, the journal of the American Medical Association. 1995, Vol 273, Num 9, pp 712-720, issn 0098-7484Article

Management and prevention of thromboembolic events in patients with cancer-related hypercoagulable states: a risky businessSARASIN, F. P; ECKMAN, M. H.Journal of general internal medicine. 1993, Vol 8, Num 9, pp 478-486, issn 0884-8734Article

Prophylactic use of the intra-aortic balloon pump in high-disk cardiac patients undergoing noncardiac surgery : a decision analytic viewGEORGESON, S; TOLBERG COOMBS, A; ECKMAN, M. H et al.The American journal of medicine. 1992, Vol 92, Num 6, pp 665-678, issn 0002-9343Article

Direct angioplasty for acute myocardial infarction : a review of outcomes in clinical subsetsECKMAN, M. H; WONG, J. B; SALEM, D. N et al.Annals of internal medicine. 1992, Vol 117, Num 8, pp 667-676, issn 0003-4819Article

HLA-matched donor registries for bone marrow transplantsECKMAN, M. H; SONNENBERG, F. A; JACOBY, I et al.International journal of technology assessment in health care. 1986, Vol 2, Num 3, pp 507-531, issn 0266-4623Article

Hormone replacement therapy : Where are we going?SANTORO, N. F; COL, N. F; MERZ, C. N. B et al.The Journal of clinical endocrinology and metabolism. 1999, Vol 84, Num 6, pp 1798-1812, issn 0021-972XArticle

Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillationECKMAN, M. H; FALK, R. H; PAUKER, S. G et al.Archives of internal medicine (1960). 1998, Vol 158, Num 15, pp 1669-1677, issn 0003-9926Article

Making decisions about antithrombotic therapy in heart disease : Decision analytic and cost-effectiveness issuesECKMAN, M. H; LEVINE, H. J; SALEM, D. N et al.Chest. 1998, Vol 114, Num 5, pp 699-714, issn 0012-3692, SUPConference Paper

Patient-specific decisions about hormone replacement therapy in postmenopausal womenCOL, N. F; ECKMAN, M. H; KARAS, R. H et al.JAMA, the journal of the American Medical Association. 1997, Vol 277, Num 14, pp 1140-1147, issn 0098-7484Conference Paper

Traitement antithrombotique dans les valvulopathies = Antithrombotic therapy in valvular heart diseaseSALEM, D. N; LEVINE, H. J; PAUKER, S. G et al.Annales de cardiologie et d'angéiologie (Paris). 2000, Vol 49, Num 2, pp 104-106, issn 0003-3928Conference Paper

Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal womenCOL, N. F; PAUKER, S. G; GOLDBERG, R. J et al.Archives of internal medicine (1960). 1999, Vol 159, Num 13, pp 1458-1466, issn 0003-9926Article

Making decisions about antithrombotic therapy in heart disease : decision analytic and cost-effectiveness issuesECKMAN, M. H; LEVINE, H. J; PAUKER, S. G et al.Chest. 1995, Vol 108, Num 4, pp 457S-470S, issn 0012-3692, SUPConference Paper

Effect of laboratory variation in the prothrombin-time ratio on the results of oral anticoagulant therapyECKMAN, M. H; LEVINE, H. J; PAUKER, S. G et al.The New England journal of medicine. 1993, Vol 329, Num 10, pp 696-702, issn 0028-4793Article

Antithrombotic therapy in valvular heart diseaseLEVINE, H. J; PAUKER, S. G; SALZMAN, E. W et al.Chest. 1992, Vol 102, Num 4, pp 434S-444S, issn 0012-3692, SUPArticle

Anticoagulation for noncardiac procedures in patients with prosthetic heart valves : does low risk mean high cost ?ECKMAN, M. H; BESHANSKY, J. R; DURAND-ZALESKI, I et al.JAMA, the journal of the American Medical Association. 1990, Vol 263, Num 11, pp 1513-1521, issn 0098-7484Article